Genetic Technologies Limited

ASX:GTG ISIN:AU000000GTG7

Genetic Technologies was an early pioneer in recognizing important new applications for "non-coding" DNA (DeoxyriboNucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Its three-pronged business strategy includes: 1) the global commercialization of its patents through an active licensing program; 2) the expansion of its dominant commercial genetic testing business in Australia; and, 3) the commercialization of its various research and development projects aimed at generating further intellectual property of global commercial significance. 
 
     

다른 언어로 보기

뉴스

1월7일 호주 시장보고서: 철광석 가격에 대한 낙관적 전망

🕔1/7/2010 9:30:30 AM 12893

수요일 호주 증시는 은행주의 부진으로 장 초반 상승 분을 반납한 채 보합세로 마감했다. 광산주는 철광석 가격에 대한 낙관적인 투자심리 덕분으로 상승했다. S&P/ASX200 지수는 1.6포인트 상승한 4925.9를 기록했고, AO 지수는 7.7포인트(0.15%) 상승한 4947.2를 기록했다.

전체 기사 읽기
###

45,897 회사 소개

  • 검색 횟수: (지난 7일간: 9) (지난 30일간: 40) (게재 이후: 6562) 

회사 데이터

    팩시밀리
  • (03) 9417 2987 
  • 주요 분야
  • 제약 / 의료 
  • 주요 기업
  • Biotechnology 
  • 홈페이지
  • www.gtg.com.au/

더 많은 뉴스 보기

  • 2024/03/26: GTG Secures Short Term Loan Facility with Radium Capital*
  • 2024/03/25: Appointment of CFO & Company Secretary*
  • 2024/03/22: GTG to develop Worlds Most Advanced Comprehensive Risk Test*
  • 2024/03/20: Results of Extraordinary General Meeting*
  • 2024/03/07: Appendix 3Y - Change of Director's Interest Notice*
  • 2024/02/28: GTG to launch U.S. Customer Digital Media Sales Campaign*
  • 2024/02/23: Appendix 4D & Half-year Financial Report - 31 December 2023*
  • 2024/02/20: Notice of Extraordinary General Meeting & Sample Proxy Form*
*refer to company website